Skip to main navigation
Skip to search
Skip to main content
Experts@Minnesota Home
Home
Profiles
Research units
University Assets
Projects and Grants
Research output
Datasets
Press/Media
Activities
Fellowships, Honors, and Prizes
Impacts
Search by expertise, name or affiliation
Surgery and actinomycin improve survival in malignant rhabdoid tumor
Ryan Horazdovsky
, J. Carlos Manivel
,
Edward Y. Cheng
Laboratory Medicine and Pathology
Orthopaedic Surgery
Screening, Prevention, Etiology & Cancer Survivorship
Research output
:
Contribution to journal
›
Article
›
peer-review
24
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Surgery and actinomycin improve survival in malignant rhabdoid tumor'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Rhabdoid Tumor
100%
Actinomycin
100%
Central Nervous System
33%
Old Age
33%
Improved Survival
33%
Meta-analysis
16%
Tumor
16%
Poor Prognosis
16%
Prognostic Factors
16%
Surgical Resection
16%
Overall Survival
16%
Age at Diagnosis
16%
Surgical Excision
16%
Demographic Variables
16%
Cox Regression
16%
Extrarenal
16%
Uncommon Tumors
16%
Kaplan-Meier Estimator
16%
Tumor Site
16%
Independent Prognostic Factor
16%
Systematic Meta-analysis
16%
Survival Disparities
16%
Soft Tissue Tumor
16%
Without Chemotherapy
16%
Two-year-olds
16%
Working Diagnosis
16%
Treatment Variable
16%
Medicine and Dentistry
Malignant Rhabdoid Tumour
100%
Dactinomycin
100%
Central Nervous System
33%
Prognostic Factor
33%
Neoplasm
16%
Systematic Review
16%
Meta-Analysis
16%
Proportional Hazards Model
16%
Overall Survival
16%
Kaplan Meier Method
16%
Soft Tissue Tumor
16%
Tumor
16%